23andMe sample genetic reports

Genetic Health Risk reports*

Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. These reports are not intended to tell a person anything about his or her current state of health, or to be used to make medical decisions, including whether or not he or she should take a medication or how much of a medication should be taken.

Genetic health risk reports package insert

Report Gene Variants Relevant Ethnicities
Report
Alpha-1 Antitrypsin Deficiency

Gene
SERPINA1
Variants2 Relevant Ethnicities
European
Report
Hereditary Thrombophilia

Gene
F2, F5
Variants2 Relevant Ethnicities
European
Report
Late-Onset Alzheimer’s Disease

Gene
APOE
Variants1 Relevant Ethnicities
European
Report
Parkinson’s Disease

Gene
LRRK2, GBA
Variants2 Relevant Ethnicities
European
, Ashkenazi Jewish
, North African Berber

*The 23andMe PGS test uses qualitative genotyping to detect clinically relevant variants in the genomic DNA of adults from saliva collected using an FDA-cleared collection device (Oragene·DX model OGD-500.001) for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. The relevance of each report varies based on ethnicity. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. These reports are not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication or how much of a medication you should take. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future or anything about the health of your fetus, or your newborn child’s risk of developing a particular disease later in life. For Gaucher Disease Type 1, we provide a single report that includes information on both carrier status and genetic health risk. The Parkinson’s Disease genetic health risk report (i) is indicated for reporting of the G2019S variant in the LRRK2 gene, and the N370S variant in the GBA gene, (ii) describes if a person has variants associated with an increased risk of developing Parkinson’s disease, and (iii) is most relevant for people of European, Ashkenazi Jewish, and North African Berber descent.

Join our education community

The 23andMe for Educators Program is designed to modernize genetics education in classrooms around the world. Registering gives educators access to the growing repository of crowd-sourced lessons, a discount on DNA kits, and email updates on new lessons and stories from the education community.